(S)-N-(1-amino-3-(4-hydroxy-3,5-diiodophenyl)-1-oxopropan-2-yl)-N-(cyanomethyl)-4-morpholinobenzamide

Catalog No. :
ACZSNT491
CAS No. :
676477-45-5
Molecular Formula :
C22H22I2N4O4
Molecular Weight :
660.25

IUPAC Name:(S)-N-(1-amino-3-(4-hydroxy-3,5-diiodophenyl)-1-oxopropan-2-yl)-N-(cyanomethyl)-4-morpholinobenzamide

(S)-N-(1-amino-3-(4-hydroxy-3,5-diiodophenyl)-1-oxopropan-2-yl)-N-(cyanomethyl)-4-morpholinobenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-N-(1-amino-3-(4-hydroxy-3,5-diiodophenyl)-1-oxopropan-2-yl)-N-(cyanomethyl)-4-morpholinobenzamide
IUPAC Name(S)-N-(1-amino-3-(4-hydroxy-3,5-diiodophenyl)-1-oxopropan-2-yl)-N-(cyanomethyl)-4-morpholinobenzamide
Molecular FormulaC22H22I2N4O4
Molecular Weight660.25
SMILESO=C(N([C@@H](CC1=CC(I)=C(O)C(I)=C1)C(N)=O)CC#N)C2=CC=C(N3CCOCC3)C=C2
InChI KeyCOEOKDKIPHMFDZ-IBGZPJMESA-N
SynonymN-(Cyanomethyl)-3,5-diiodo-Nα-[4-(4-morpholinyl)benzoyl]-L-tyrosinamide;N-(Cyanomethyl)-3,5-diiodo-N(alpha)-[4-(4-morpholinyl)benzoyl]-L-tyrosinamide;Benzenepropanamide, N-(cyanomethyl)-4-hydroxy-3,5-diiodo-α-[[4-(4-morpholinyl)benzoyl]amino]-, (αS)-
CAS No.676477-45-5

Synthetic Route by SureRoute

1. ACZSNT491 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEFXM458 route compound structure diagram
    ACEFXM4587470-38-4 In Stock
  4. Then
  5. ACZSNT491 route product structure diagram
    ACZSNT491676477-45-5
Inquiry

2. ACZSNT491 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZSNT491 route product structure diagram
    ACZSNT491676477-45-5
Inquiry

Comments (0)